Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might ...

Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.

are typically adult skin or blood cells that have been reprogrammed in a lab to become like embryonic stem cells, which are ...

Japan 2 Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan To make decisions for treatment, adult T-cell leukemia ...

Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also ...

Keio University researchers used induced pluripotent stem cells (iPS cells) created by stimulating mature, specialized cells ...

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate ... activities in the OA joint. Targeted gene therapy might further enhance these activities of MSCs.

Okano noted that the medical trial used induced pluripotent stem (iPS) cells, which basically means they are normal adult cells which have been reprogrammed to act like the embryonic stem cells ...

The stem cell treatment involved the injection of roughly two million reprogrammed or induced pluripotent stem (iPS) cells, which are created by hacking adult cells back into an embryonic-like state.